Autologous OC-DC Vaccine（Centre Hospitalier Universitaire Vaudois）
- Generic Name
- Autologous OC-DC Vaccine（Centre Hospitalier Universitaire Vaudois）
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma
Phase 1
Withdrawn
- Conditions
- Ovarian Carcinoma
- Interventions
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Centre Hospitalier Universitaire Vaudois
- Target Recruit Count
- 16
- Registration Number
- NCT05714306
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath